ArticleLeukemia2014

B-lymphoid tyrosine kinase (Blk) is an oncogene and a potential target for therapy with dasatinib in cutaneous T-cell lymphoma (CTCL).

D L Petersen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.